About Us
Meet the people behind Variant Bio
Our team's expertise spans genetics, molecular biology, therapeutics, anthropology, and ethics. We are united in the belief that human genomics has the power to transform drug development.
David McElligott, PhD
Former CSO, Petra Pharma
Evan Eichler, PhD
Professor of Genome Sciences, HHMI Investigator, University of Washington
Gosia Trynka, PhD
Group Leader, Wellcome Sanger Institute, Experimental Science Director, Open Targets
Karen Akinsanya, PhD
Executive Vice President, Chief Biomedical Scientist, Head of Discovery R&D, Schrödinger
Rob Scott, MD
Former CMO, Abbvie
Ryan Hernandez, PhD
Professor of Bioengineering and Therapeutic Sciences, UC San Francisco
Tuuli Lappalainen, PhD
Professor, KTH Royal Institute of Technology, Senior Associate Member, New York Genome Center
Our Investors
